On Watch For Breakout In Shares Of Intercept Pharmaceuticals Inc

These biotechs (not to be conflated with the big pharma stocks) are well suited for the "bottom-up" investing if one can tolerate the added risk. Although they tend to be more volatile than the broad markets in most cases, most of their movement (up or down) is based upon what happens with their drugs - clinical trials, FDA decisions, etc... and somewhat on M&A activity and speculation as well.

I sold half of my LOXO this morning at ~ $165 for a nice profit on such good news: https://seekingalpha.com/article/41...s-cimzia-trial-success-audentes-positive-data

 

https://www.marketwatch.com/investing/stock/loxo